Beijing Tide Pharmaceutical Co., Ltd

This study tests a new drug called TCC1727 combined with other cancer treatments (benmelstobart, olaparib, or topotecan) for people with advanced solid tumors that have stopped responding to standard therapy. The goal is to find the safest dose and see if the combination can shri…

This study tests a new drug called TDI01 for people with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. About 508 adults in China will receive either TDI01 or a placebo to see if the drug helps preserve lung function over 24 to …

This study tests a new painkiller called TRD205 for people recovering from hip replacement surgery. About 200 adults will receive either TRD205, an active comparator, or a placebo to see how well it controls pain and if it is safe. The goal is to find a better way to manage pain …

This early-stage study is testing whether an inhaled drug called CPD704 is safe and how it behaves in the body. It involves 90 healthy Chinese adults aged 18–55. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.